Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy
Status:
Unknown status
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy and safety of prednisone versus
sub-antimicrobial dose doxycycline (50 mg/d) in the treatment of active moderate-severe
Graves' Orbitopathy (GO).